-
[
Science,
1996]
The one-cell animal embryo, or zygote, faces a daunting engineering task: implementing the architectural plans inscribed in its DNS for building a complex, multicelled body. So, like any sensible construction supervisor, the zygote swiftly divides the project into manageable chunks, assigning some of its progeny to build only gut, for example, and other to make only muscle or skin. Just how each early embryonic cell gets its orders is understood only for the fruit fly Drosophila melanogaster-an achievement that helped win 1995's Nobel Prize in medicine for three developmental biologists. Now, however, the communication lines governing embryonic development are emerging in another animal beloved of developmental researchers: the tiny worm known as Caenorhabditis elegans.
-
McElhaney J, McCarter R, Chesselet MF, Austad S, Blau H, Saag M, Lundblad V, Johnson TE, Effros RB, Kaeberlein M, Ingram D
[
J Gerontol A Biol Sci Med Sci,
2008]
In this era of genomics and other exciting technical advances, research on the biology of aging is undergoing a renaissance. This report summarizes 10 cutting-edge areas of research covered in symposia that spanned such topics as stem cells, novel vaccine strategies, nutritional sensing, new concepts of Parkinson''s disease, high throughput screening for aging interventions, manipulating telomerase in cancer and immunodeficiency, synergy between aging and HIV disease, and epigenetic influences on aging. Novel animal models, including those showing no evidence of aging, as well as ethical and political implications of embryonic stem cells and alternative medicine are also discussed.
-
[
IDrugs,
2010]
CHI''s Seventh Annual Conference on High-Content Analysis (HCA), held in San Francisco, incorporated topics covering new developments in the field of HCA, including hardware and software updates, new biological models for HCA and pathway analysis. This conference report highlights selected presentations on the use of HCA for the characterization of stem cells, cell-colony analysis, the validation of disease models and the identification of antiparasitic compounds.
-
Rebholz-Schuhmann D, Kowald A, Hoeijemakers J, Schmitz U, Stolzing A, Dengjel J, Suhnel J, Schmeck B, Fuellen G, Priebe S, Wuttke D, Vera J, Kestler HA, Hoeflich A
[
Rejuvenation Res,
2012]
In an "aging society," health span extension is most important. As in 2010, talks in this series of meetings in Rostock-Warnemunde demonstrated that aging is an apparently very complex process, where computational work is most useful for gaining insights and to find interventions that counter aging and prevent or counteract aging-related diseases. The specific topics of this year's meeting entitled, "RoSyBA: Rostock Symposium on Systems Biology and Bioinformatics in Ageing Research," were primarily related to "Cancer and Aging" and also had a focus on work funded by the German Federal Ministry of Education and Research (BMBF). The next meeting in the series, scheduled for September 20-21, 2013, will focus on the use of ontologies for computational research into aging, stem cells, and cancer. Promoting knowledge formalization is also at the core of the set of proposed action items concluding this report.
-
[
J Gerontol A Biol Sci Med Sci,
2015]
In June 2013, a workshop was convened in San Francisco to explore, in depth, the role of the Forkhead transcription factor FOXO3 (and related FOXOs) in development, aging, and, in particular, exceptional longevity. The presentations covered results derived from model systems, computational analysis and bioinformatics, and genomics and genome-wide association studies of a number of cohorts. Although the data collectively strongly reinforce FOXO3 and the FOXO/FOXO3 pathway as very important determinants in aging and life span, much of the detail of how the latter is achieved still remains unknown, in part, because of the very large number of genes (~2,200 in Caenorhabditis elegans) the transcription factor is involved in helping regulate. Particularly challenging at the present time is understanding the association of apparently nonfunctional specific variants (single nucleotide polymorphisms) of FOXO3 and exceptional longevity in humans, a finding replicated in a number of studies. Nonetheless, as summarized in this report, valuable information and insights were presented at the workshop on the transcription factor including but not limited to its role in determining longevity in C elegans and Drosophila (in flies, eg, an important interaction in aging occurs between dFOXO and the transforming growth factor-/activin pathway), stem cell function and aging (notably in hematopoiesis), downstream regulatory activity (eg, by binding near sites of RNAse occupancy and altering chromatin structure), and as a potential target for the development a healthy aging drug (in this example, using compounds developed and screened to effect FOXO function in cancer cells).